CEMKA CEO, Bruno Detournay has coordinated more than 500 studies in the fields of health economics, outcomes research and epidemiology during his twenty-five years experience. The results of Bruno Detournay’s work conducted for a number of national and international institutions and the pharmaceutical and bio-medical industry has led to more than 150 published articles. Vice-President of the French College of Health Economists (Collège des Economistes de la Santé), member of the International Society for Pharmacoeconomics and Outcomes Research, and several other scientific societies. Bruno Detournay is also a regular lecturer in Health Economy and Outcomes research (Dauphine University, Paris, René Descartes University, Paris, Pierre et Marie Curie University, Paris, Créteil Val de Marne University, Créteil, Conservatoire National des Arts et Métiers, Paris, etc.). Bruno Detournay is a medical doctor (Université Paris VI Pierre et Marie Curie) with a specialization on health issues in developing countries and tropical medicine. He holds an MBA from the ESSEC (Ecole Supérieure des Sciences Economiques et Commerciales) and was an alumnus of the chair ESSEC-Health. He also holds a master’s degree in health economics (Université Paris I – Panthéon Sorbonne).